| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/29/2010 | US20100189722 Anti cd37 antibodies |
| 07/29/2010 | US20100189720 Novel card proteins involved in cell death regulation |
| 07/29/2010 | US20100189719 using monoclonal antibody or an Fab fragment capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, age-induced macular degeneration |
| 07/29/2010 | US20100189718 Molecules with extended half-lives, compositions and uses thereof |
| 07/29/2010 | US20100189717 Plant Recombinant Human CTLA4IG and a Method for Producing the Same |
| 07/29/2010 | US20100189715 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/29/2010 | US20100189714 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 07/29/2010 | US20100189706 Polypeptide enzymes that can hydrolyze lignocellulose such as sugarcane bagasse, i.e., for biomass processing, industrial uses such as disinfectants, pharmaceuticals, waste treatment, making biofuels, feeds and foods; bioconversion of lignocellulosic residues into fermentable sugars; heat stability |
| 07/29/2010 | US20100189689 Tetrameric Cytokines with Improved Biological Activity |
| 07/29/2010 | US20100189686 Albumin Fusion Proteins |
| 07/29/2010 | US20100189682 Biologically active proteins having increased In Vivo and/or In Vitro stability |
| 07/29/2010 | US20100189657 Intramolecularly quenched fluorochrome conjugates and methods of use |
| 07/29/2010 | US20100189652 Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof |
| 07/29/2010 | US20100189651 Modified antibody compositions, methods of making and using thereof |
| 07/29/2010 | US20100189649 Monoclonal antibodies to activated erbb family members and methods of use |
| 07/29/2010 | CA2750581A1 Pta089 protein |
| 07/29/2010 | CA2750533A1 Stabilized fc polypeptides with reduced effector function and methods of use |
| 07/29/2010 | CA2750444A1 Anti-cd 160 monoclonal antibodies and uses thereof |
| 07/28/2010 | EP2210945A2 Neisseria meningitidis antigens |
| 07/28/2010 | EP2210940A1 Method for high-level secretion and production of protein |
| 07/28/2010 | EP2210939A1 Anti-bst2 antibody |
| 07/28/2010 | EP2210903A1 Anti-CD160 monoclonal antibodies and uses thereof |
| 07/28/2010 | EP2210902A1 Recombinant monovalent antibodies |
| 07/28/2010 | EP2210901A1 Antibody capable of specifically binding to a oligomer, and use thereof |
| 07/28/2010 | EP2209810A1 Viral therapeutic |
| 07/28/2010 | EP2209809A1 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes |
| 07/28/2010 | EP2209808A1 Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates |
| 07/28/2010 | EP2209807A1 Anti-factor b antibodies and their uses |
| 07/28/2010 | EP2209806A1 Anti-hepcidin antibodies and uses thereof |
| 07/28/2010 | EP2209805A1 An antigen associated with rheumatoid arthritis |
| 07/28/2010 | EP2209804A1 Monoclonal antibody for app |
| 07/28/2010 | EP2209803A1 Antibodies that bind to mammalian ngal and uses thereof |
| 07/28/2010 | EP2209802A1 Resistin antagonists and their use |
| 07/28/2010 | EP2209799A2 Breast cancer associated antigen |
| 07/28/2010 | EP2209498A2 Treatment of proliferative disorders using antibodies to psma |
| 07/28/2010 | EP2209495A1 Taz/wwtr1 for diagnosis and treatment of cancer |
| 07/28/2010 | EP2209491A2 Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6) |
| 07/28/2010 | EP1776387B1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 07/28/2010 | EP1606317B1 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 07/28/2010 | EP1587921B1 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 07/28/2010 | EP1487856B1 Human antibodies specific to kdr and uses thereof |
| 07/28/2010 | EP1397486B1 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 07/28/2010 | EP1315831B1 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 07/28/2010 | CN1651457B Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens |
| 07/28/2010 | CN101790540A Local administration of chicken yolk immune globulins (igy) to treat and prevent fungal infections |
| 07/28/2010 | CN101787080A Method for preparing anti-H1N1 specific immunoglobulin of egg yolk |
| 07/28/2010 | CN101787079A High-purity horse anti-rabies virus antibody F(ab')2 fragment |
| 07/28/2010 | CN101787072A Specific binding agents of human angiopoietin-2 |
| 07/28/2010 | CN101284875B X-type gluten subunit monoclonal antibody of high molecular weight and uses thereof |
| 07/28/2010 | CN101016547B Method of preparing ocean double RNA virus MABV recombination albumen and application thereof |
| 07/27/2010 | USRE41461 Purification, composition and specificity of Heparinase I, II, and III from Flavobacterium heparinum |
| 07/27/2010 | US7763719 Detecting tumor cells expressing TAG-72 using CC49 in which less than all six (three heavy chain and three light chain) Complementarity Determining Regions are present; host cells |
| 07/27/2010 | US7763716 monoclonal antibodies capable of recognizing and neutralizing neuropeptide W (NPW) an endogenous ligands for human G protein coupled receptors, used in the medical diagnosis and preventing of infertility, kidney edema, peptic ulcer, gastric hyperacidity |
| 07/27/2010 | US7763710 ALS-specific peptide composition |
| 07/27/2010 | US7763709 purified immunoglobulin (IgE) binding immunogenic proteins, used in test kit for screening patients for allergies to food nuts |
| 07/27/2010 | US7763705 Viral peptides for use in activating immune response to treat and prevent viral infection |
| 07/27/2010 | US7763586 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 07/27/2010 | US7763435 Method for diagnosis of alzheimer's disease with determination of LASP-1 immunoreactivity |
| 07/27/2010 | US7763434 monoclonal antibodies against interleukin-15(IL-15) that prevent IL-15 from effecting signal transduction through the beta - or gamma -subunits of the IL-15 receptor complex; treating transplant rejection and graft-versus-host disease |
| 07/27/2010 | US7763262 Attenuated yiaO mutants of Pasteurellaceae bacteria |
| 07/27/2010 | US7763258 Used to assess protein binding interactions |
| 07/27/2010 | US7763251 Kits to assess the risk of tumor progression |
| 07/27/2010 | US7763249 Brain protein specific immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease |
| 07/27/2010 | US7763248 Humanized collagen antibodies and related methods |
| 07/27/2010 | US7763247 Humanized collagen antibodies and related methods |
| 07/27/2010 | US7763246 Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor |
| 07/27/2010 | US7763244 Immunoglobulins; competitive binding; gene expression inhibition; for prevention and treatment of gastrointestinal tract cancers, inflammatory bowel disorders, and diabetes |
| 07/27/2010 | US7763243 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient. |
| 07/27/2010 | CA2690899A1 An imaging system and process using monoclonal antibodies |
| 07/27/2010 | CA2479270C Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases |
| 07/27/2010 | CA2477163C Soluble form of carbonic anhydrase ix (s-ca-ix), assays to detect s-ca ix, and ca ix's coexpression with her-2/neu/c-erbb-2, and ca ix-specific monoclonal antibodies to non-immunodominant epitopes |
| 07/27/2010 | CA2462686C Fret protease assays for clostridial toxins |
| 07/27/2010 | CA2375820C The myostatin gene promoter and inhibition of activation thereof |
| 07/27/2010 | CA2339870C Antithrombin nucleotides and proteins from horn fly |
| 07/27/2010 | CA2338989C Antibodies for detecting microorganisms |
| 07/27/2010 | CA2323091C Nephrin gene and protein |
| 07/27/2010 | CA2287872C Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/27/2010 | CA2195385C An artificial recombinant substrate (ragg 1) and native aggrecan to study the proteolytic activity of 'aggrecanase' in cell culture systems |
| 07/22/2010 | WO2010083253A2 Cd47 related compositions and methods for treating immunological diseases and disorders |
| 07/22/2010 | WO2010082894A1 Precipitation of biomolecules with negatively charged polymers |
| 07/22/2010 | WO2010082136A1 Recombinant monovalent antibodies |
| 07/22/2010 | WO2010082134A1 Combination antibodies for the treatment and prevention of disease caused by bacillus anthracis and related bacteria and their toxins |
| 07/22/2010 | WO2010082034A1 Antibody |
| 07/22/2010 | WO2010081897A1 Process for engineering polyvalent, polyspecific fusion proteins using uteroglobin as skeleton and so obtained products |
| 07/22/2010 | WO2010081890A1 Anti-kir3d antibodies |
| 07/22/2010 | WO2010081856A1 Pulmonary administration of immunoglobulin single variable domains and constructs thereof |
| 07/22/2010 | WO2010081787A1 IMPROVED TNFα ANTAGONISM, PROPHYLAXIS & THERAPY WITH REDUCED ORGAN NECROSIS |
| 07/22/2010 | WO2010081738A1 Vaccine compositions |
| 07/22/2010 | WO2010081679A2 Antibodies against human epo receptor |
| 07/22/2010 | WO2010057882A3 Composition for producing anti-amyloid beta peptide antibodies with d-peptides |
| 07/22/2010 | WO2010056948A3 Humanized anti-il-6 antibodies |
| 07/22/2010 | WO2010051502A3 Light targeting molecules and uses thereof |
| 07/22/2010 | WO2010037837A3 Bispecific single chain antibodies with specificity for high molecular weight target antigens |
| 07/22/2010 | WO2010037836A3 Cross-species-specific psmaxcd3 bispecific single chain antibody |
| 07/22/2010 | WO2010033923A3 Genus-wide chlamydial peptide vaccine antigens |
| 07/22/2010 | WO2010027370A9 Compositions and methods for the treatment of solid tumor cancers |
| 07/22/2010 | US20100186101 Diagnosis and treatment of fertility conditions using a serine protease |
| 07/22/2010 | US20100186100 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 07/22/2010 | US20100184960 Antibodies Against Human IL-22 And Uses Therefor |
| 07/22/2010 | US20100184959 Polypeptide Variants |